世界の自己免疫疾患用装置開発動向:医療機器パイプライン分析2015

◆英語タイトル:Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015
◆商品コード:GDME0148EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年1月5日
◆ページ数:295
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥912,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,368,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、自己免疫疾患用装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・自己免疫疾患用装置の概要
・自己免疫疾患用装置の開発動向:開発段階別分析
・自己免疫疾患用装置の開発動向:セグメント別分析
・自己免疫疾患用装置の開発動向:領域別分析
・自己免疫疾患用装置の開発動向:規制Path別分析
・自己免疫疾患用装置の開発動向:承認日(推定)別分析
・企業別自己免疫疾患用装置の開発動向(パイプライン製品、進行中の治験)
・自己免疫疾患用装置の最近動向
【レポートの概要】

Auto-Immune Diseases – Medical Devices Pipeline Assessment, 2015

Summary

GlobalData’s Medical Devices sector report, “Auto-Immune Diseases – Medical Devices Pipeline Assessment, 2015″ provides an overview of Auto-Immune Diseases currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Auto-Immune Diseases pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Auto-Immune Diseases under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Auto-Immune Diseases and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Auto-Immune Diseases under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 18
2 Introduction 19
2.1 Auto-Immune Diseases Overview 19
3 Products under Development 20
3.1 Auto-Immune Diseases – Pipeline Products by Stage of Development 20
3.2 Auto-Immune Diseases – Pipeline Products by Territory 21
3.3 Auto-Immune Diseases – Pipeline Products by Regulatory Path 22
3.4 Auto-Immune Diseases – Pipeline Products by Estimated Approval Date 23
4 Auto-Immune Diseases – Pipeline Products under Development by Companies 24
4.1 Auto-Immune Diseases Companies – Pipeline Products by Stage of Development 24
4.2 Auto-Immune Diseases – Pipeline Products by Stage of Development 28
5 Auto-Immune Diseases Companies and Product Overview 35
5.1 Adaptive Biotechnologies Corporation Company Overview 35
5.1.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
5.2 Agena Bioscience, Inc Company Overview 36
5.2.1 Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.3 Albert-Ludwigs-Universitat Freiburg Company Overview 37
5.3.1 Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview 37
5.4 Alere Inc. Company Overview 40
5.4.1 Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.5 Amarantus Bioscience Holdings, Inc. Company Overview 43
5.5.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.6 Amdix B.V. Company Overview 46
5.6.1 Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 Analyticon Biotechnologies AG Company Overview 47
5.7.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 47
5.8 apDia n.v. Company Overview 48
5.8.1 apDia n.v. Pipeline Products & Ongoing Clinical Trials Overview 48
5.9 Autoimmune Technologies, LLC Company Overview 49
5.9.1 Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.10 Beckman Coulter, Inc. Company Overview 55
5.10.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.11 BG Medicine, Inc. Company Overview 57
5.11.1 BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.12 Biocortech Company Overview 59
5.12.1 Biocortech Pipeline Products & Ongoing Clinical Trials Overview 59
5.13 Biogen, Inc. Company Overview 60
5.13.1 Biogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.14 Biomedal S.L. Company Overview 62
5.14.1 Biomedal S.L. Pipeline Products & Ongoing Clinical Trials Overview 62
5.15 Biomerica, Inc. Company Overview 66
5.15.1 Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.16 Bionure Farma, S.L. Company Overview 70
5.16.1 Bionure Farma, S.L. Pipeline Products & Ongoing Clinical Trials Overview 70
5.17 Bio-Rad Laboratories, Inc. Company Overview 71
5.17.1 Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.18 BioRap Technologies Ltd. Company Overview 73
5.18.1 BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
5.19 Boston University Company Overview 74
5.19.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 74
5.20 CareDx, Inc. Company Overview 75
5.20.1 CareDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.21 CD Diagnostics, Inc. Company Overview 77
5.21.1 CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 Chronix Biomedical, Inc. Company Overview 78
5.22.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.23 Co-Diagnostics HBDC, Inc. Company Overview 81
5.23.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.24 Crescendo Bioscience, Inc. Company Overview 82
5.24.1 Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.25 Digna Biotech, S.L. Company Overview 86
5.25.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 86
5.26 Durin Technologies, Inc. Company Overview 90
5.26.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.27 Enterome Bioscience SA Company Overview 91
5.27.1 Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 91
5.28 Ezose Sciences Inc. Company Overview 93
5.28.1 Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.29 Flamentera AG Company Overview 94
5.29.1 Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview 94
5.30 Genalyte, Inc. Company Overview 95
5.30.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.31 Genentech, Inc. Company Overview 96
5.31.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.32 GeNeuro SA Company Overview 99
5.32.1 GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview 99
5.33 Glycominds Ltd. Company Overview 101
5.33.1 Glycominds Ltd. Pipeline Products & Ongoing Clinical Trials Overview 101
5.34 Grifols, S.A. Company Overview 102
5.34.1 Grifols, S.A. Pipeline Products & Ongoing Clinical Trials Overview 102
5.35 Hannover Medical School Company Overview 104
5.35.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 104
5.36 Helmholtz Centre for Infection Research Company Overview 105
5.36.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 HOB Biotech Group Co., Ltd. Company Overview 106
5.37.1 HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.38 Hospital for Special Surgery Company Overview 107
5.38.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 107
5.39 Hycor Biomedical Inc. Company Overview 108
5.39.1 Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
5.40 Ignyta, Inc. Company Overview 110
5.40.1 Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.41 ImmusanT, Inc. Company Overview 114
5.41.1 ImmusanT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114
5.42 Innobiochips Company Overview 115
5.42.1 Innobiochips Pipeline Products & Ongoing Clinical Trials Overview 115
5.43 INOVA Diagnostics, Inc. Company Overview 116
5.43.1 INOVA Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.44 Institut National de la Sante et de la Recherche Medicale Company Overview 126
5.44.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 126
5.45 Is Diagnostics Company Overview 127
5.45.1 Is Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 127
5.46 LineaGen, Inc. Company Overview 128
5.46.1 LineaGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 128
5.47 Lophius Biosciences GmbH Company Overview 129
5.47.1 Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 129
5.48 Louisville Bioscience, Inc. Company Overview 130
5.48.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.49 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview 134
5.49.1 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Pipeline Products & Ongoing Clinical Trials Overview 134
5.50 Medica Corporation Company Overview 135
5.50.1 Medica Corporation Pipeline Products & Ongoing Clinical Trials Overview 135
5.51 Metabolomic Technologies Inc. Company Overview 138
5.51.1 Metabolomic Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 Metanomics Health GmbH Company Overview 142
5.52.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 142
5.53 MSDx, Inc. Company Overview 143
5.53.1 MSDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143
5.54 Myriad Genetics, Inc. Company Overview 147
5.54.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.55 Nanosphere, Inc. Company Overview 149
5.55.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.56 Neuro Vigor, LLC Company Overview 151
5.56.1 Neuro Vigor, LLC Pipeline Products & Ongoing Clinical Trials Overview 151
5.57 Northwestern University Company Overview 152
5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 152
5.58 NoToPharm s.r.l. Company Overview 154
5.58.1 NoToPharm s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 154
5.59 NOWDiagnostics Company Overview 162
5.59.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 162
5.60 OmniBiome Therapeutics Inc. Company Overview 163
5.60.1 OmniBiome Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 163
5.61 One Way Liver Genomics, S.L. Company Overview 164
5.61.1 One Way Liver Genomics, S.L. Pipeline Products & Ongoing Clinical Trials Overview 164
5.62 OPKO Health, Inc. Company Overview 166
5.62.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.63 Oxford Gene Technology Limited Company Overview 168
5.63.1 Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 168
5.64 Oxford Immunotec Limited Company Overview 169
5.64.1 Oxford Immunotec Limited Pipeline Products & Ongoing Clinical Trials Overview 169
5.65 Pediatric Bioscience, LLC Company Overview 170
5.65.1 Pediatric Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 170
5.66 Progentec Diagnostics, Inc. Company Overview 171
5.66.1 Progentec Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.67 Protagen AG Company Overview 172
5.67.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 172
5.68 ProteinLogic Ltd Company Overview 182
5.68.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 182
5.69 Quanterix Corporation Company Overview 183
5.69.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 183
5.70 Regulus Therapeutics Inc. Company Overview 184
5.70.1 Regulus Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.71 Rice University Company Overview 186
5.71.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 186
5.72 Roche Diagnostics International Ltd. Company Overview 187
5.72.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 187
5.73 Shuwen Biotech Co. Ltd. Company Overview 193
5.73.1 Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 193
5.74 Singulex, Inc. Company Overview 194
5.74.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 194
5.75 SomaLogic, Inc. Company Overview 195
5.75.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 195
5.76 Southern Illinois University Carbondale Company Overview 196
5.76.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 196
5.77 SQI Diagnostics Inc. Company Overview 198
5.77.1 SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 198
5.78 The Johns Hopkins University Company Overview 207
5.78.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 207
5.79 The Walter and Eliza Hall Institute of Medical Research Company Overview 210
5.79.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 210
5.80 TheraDiag SA Company Overview 211
5.80.1 TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview 211
5.81 Thermo Fisher Scientific Inc. Company Overview 213
5.81.1 Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 213
5.82 Toscana Biomarkers Srl Company Overview 237
5.82.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 237
5.83 Univalue Valorizacion, S.L. Company Overview 243
5.83.1 Univalue Valorizacion, S.L. Pipeline Products & Ongoing Clinical Trials Overview 243
5.84 University of California, San Francisco Company Overview 244
5.84.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 244
5.85 University of Chicago Company Overview 247
5.85.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 247
5.86 University of Colorado Company Overview 248
5.86.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 248
5.87 University of Florida Company Overview 249
5.87.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 249
5.88 University of Manchester Company Overview 250
5.88.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 250
5.89 University of Oxford Company Overview 252
5.89.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 252
5.90 University of Pecs Company Overview 256
5.90.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 256
5.91 University Rovira i Virgili Company Overview 257
5.91.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 257
5.92 US Biomarkers, Inc. Company Overview 258
5.92.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 258
5.93 Washington University in St. Louis Company Overview 259
5.93.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 259
5.94 XAir Diagnostics B.V. Company Overview 260
5.94.1 XAir Diagnostics B.V. Pipeline Products & Ongoing Clinical Trials Overview 260
5.95 XEPTAGEN SpA Company Overview 261
5.95.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 261
5.96 Yale University Company Overview 262
5.96.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 262
6 Auto-Immune Diseases- Recent Developments 263
7 Appendix 292
7.1 Methodology 292
7.2 About GlobalData 294
7.3 Contact Us 295
7.4 Disclaimer 295

1.1 List of Tables
Table 1: Auto-Immune Diseases - Pipeline Products by Stage of Development 20
Table 2: Auto-Immune Diseases - Pipeline Products by Territory 21
Table 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path 22
Table 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 23
Table 5: Auto-Immune Diseases Companies - Pipeline Products by Stage of Development 24
Table 6: Auto-Immune Diseases - Pipeline Products by Stage of Development 28
Table 7: Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
Table 8: Diagnostic Test - Auto-Immune Disease - Product Status 35
Table 9: Diagnostic Test - Auto-Immune Disease - Product Description 35
Table 10: Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 11: AttoSense Lupus Panel - Product Status 36
Table 12: AttoSense Lupus Panel - Product Description 36
Table 13: Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview 37
Table 14: Biomarker Based Assay - Systemic Sclerosis - Product Status 38
Table 15: Biomarker Based Assay - Systemic Sclerosis - Product Description 38
Table 16: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Status 39
Table 17: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Description 39
Table 18: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 19: AIMS System - Cardiolipin IgG Test - Product Status 41
Table 20: AIMS System - Cardiolipin IgG Test - Product Description 41
Table 21: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Status 42
Table 22: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Description 42
Table 23: Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 24: Diagnostic Assay - Neuromyelitis Optica - Product Status 44
Table 25: Diagnostic Assay - Neuromyelitis Optica - Product Description 44
Table 26: Diagnostic Assay - Paraneoplastic Disease - Product Status 45
Table 27: Diagnostic Assay - Paraneoplastic Disease - Product Description 45
Table 28: Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 29: Chitotriosidase Biomarker - Mutiple Sclerosis - Product Status 46
Table 30: Chitotriosidase Biomarker - Mutiple Sclerosis - Product Description 46
Table 31: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 47
Table 32: Turbitex IgA - Product Status 47
Table 33: Turbitex IgA - Product Description 47
Table 34: apDia n.v. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 35: Diagnostic Test - MS - Product Status 48
Table 36: Diagnostic Test - MS - Product Description 48
Table 37: Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
Table 38: Anti-Squalene Antibody Assay - Product Status 50
Table 39: Anti-Squalene Antibody Assay - Product Description 50
Table 40: Autoimmune Disease Virus Assay - Graves' Disease - Product Status 51
Table 41: Autoimmune Disease Virus Assay - Graves' Disease - Product Description 51
Table 42: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Status 52
Table 43: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Description 52
Table 44: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Status 53
Table 45: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Description 53
Table 46: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Status 54
Table 47: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Description 54
Table 48: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 49: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Status 55
Table 50: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Description 55
Table 51: SYNCHRON LXi 725 IL-6 Assay - Product Status 56
Table 52: SYNCHRON LXi 725 IL-6 Assay - Product Description 56
Table 53: BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
Table 54: Diagnostic Assay - Multiple Sclerosis - Product Status 58
Table 55: Diagnostic Assay - Multiple Sclerosis - Product Description 58
Table 56: Biocortech Pipeline Products & Ongoing Clinical Trials Overview 59
Table 57: Blood Test - Cognitive Deficits - Product Status 59
Table 58: Blood Test - Cognitive Deficits - Product Description 59
Table 59: Biogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 60: Companion Diagnostic Test - Sjögren's Syndrome - Product Status 61
Table 61: Companion Diagnostic Test - Sjögren's Syndrome - Product Description 61
Table 62: Biomedal S.L. Pipeline Products & Ongoing Clinical Trials Overview 62
Table 63: ELISA DELIAC GFD - Product Status 63
Table 64: ELISA DELIAC GFD - Product Description 63
Table 65: IVYLISA DGP8 - Product Status 64
Table 66: IVYLISA DGP8 - Product Description 64
Table 67: Stick DELIAC GFD - Product Status 65
Table 68: Stick DELIAC GFD - Product Description 65
Table 69: Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 70: Anti-Gliadin IgA Elisa Kit - Product Status 67
Table 71: Anti-Gliadin IgA Elisa Kit - Product Description 67
Table 72: Anti-Gliadin IgG Elisa Kit - Product Status 68
Table 73: Anti-Gliadin IgG Elisa Kit - Product Description 68
Table 74: Transglutaminase Elisa Kit - Product Status 69
Table 75: Transglutaminase Elisa Kit - Product Description 69
Table 76: Bionure Farma, S.L. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 77: BN - 301 Diagnostic/Prognostic Test - Product Status 70
Table 78: BN - 301 Diagnostic/Prognostic Test - Product Description 70
Table 79: Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 80: EVOLIS - Autoimmune Panel - Product Status 72
Table 81: EVOLIS - Autoimmune Panel - Product Description 72
Table 82: BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
Table 83: Biomarker Test - Multiple Sclerosis - Product Status 73
Table 84: Biomarker Test - Multiple Sclerosis - Product Description 73
Table 85: Boston University Pipeline Products & Ongoing Clinical Trials Overview 74
Table 86: Blood-Based Diagnostic Test - Nephropathy - Product Status 74
Table 87: Blood-Based Diagnostic Test - Nephropathy - Product Description 74
Table 88: CareDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 89: Diagnostic Test - Crohn's Disease - Product Status 76
Table 90: Diagnostic Test - Crohn's Disease - Product Description 76
Table 91: CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
Table 92: Cygnasure Diagnostic Immunoassay - Lupus - Product Status 77
Table 93: Cygnasure Diagnostic Immunoassay - Lupus - Product Description 77
Table 94: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 95: Companion Diagnostic Test - Multiple Sclerosis - Product Status 79
Table 96: Companion Diagnostic Test - Multiple Sclerosis - Product Description 79
Table 97: Companion Diagnostic Test - Systemic Lupus Erythematous - Product Status 80
Table 98: Companion Diagnostic Test - Systemic Lupus Erythematous - Product Description 80
Table 99: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
Table 100: Diagnostic Test - Auto-immune Disorder - Product Status 81
Table 101: Diagnostic Test - Auto-immune Disorder - Product Description 81
Table 102: Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 103: Multi-Biomarker Test - Ankylosing Spondylitis - Product Status 83
Table 104: Multi-Biomarker Test - Ankylosing Spondylitis - Product Description 83
Table 105: Multi-Biomarker Test - Psoriatic Arthritis - Product Status 84
Table 106: Multi-Biomarker Test - Psoriatic Arthritis - Product Description 84
Table 107: Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Status 85
Table 108: Multi-Biomarker Test - Systemic Lupus Erythematosus - Product Description 85
Table 109: Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 86
Table 110: Anti-CD-137 Antibodies Assay - Product Status 87
Table 111: Anti-CD-137 Antibodies Assay - Product Description 87
Table 112: MTA - Multiple Sclerosis Assay - Product Status 88
Table 113: MTA - Multiple Sclerosis Assay - Product Description 88
Table 114: Prognostic Test - Multiple Sclerosis - Product Status 89
Table 115: Prognostic Test - Multiple Sclerosis - Product Description 89
Table 116: Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
Table 117: Diagnostic Test - Parkinson's Disease - Product Status 90
Table 118: Diagnostic Test - Parkinson's Disease - Product Description 90
Table 119: Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 91
Table 120: Diagnostic Test - Multiple Sclerosis - Product Status 91
Table 121: Diagnostic Test - Multiple Sclerosis - Product Description 91
Table 122: Diagnostic Test - Type 2 Diabetes - Product Status 92
Table 123: Diagnostic Test - Type 2 Diabetes - Product Description 92
Table 124: Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
Table 125: Biomarker Diagnostic Assay - Multiple Sclerosis - Product Status 93
Table 126: Biomarker Diagnostic Assay - Multiple Sclerosis - Product Description 93
Table 127: Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview 94

1.2 List of Figures
Figure 1: Auto-Immune Diseases - Pipeline Products by Stage of Development 20
Figure 2: Auto-Immune Diseases - Pipeline Products by Territory 21
Figure 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path 22
Figure 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 23

【掲載企業】

Adaptive Biotechnologies Corporation
Agena Bioscience, Inc
Albert-Ludwigs-Universitat Freiburg
Alere Inc.
Amarantus Bioscience Holdings, Inc.
Amdix B.V.
Analyticon Biotechnologies AG
apDia n.v.
Autoimmune Technologies, LLC
Beckman Coulter, Inc.
BG Medicine, Inc.
Biocortech
Biogen, Inc.
Biomedal S.L.
Biomerica, Inc.
Bionure Farma, S.L.
Bio-Rad Laboratories, Inc.
BioRap Technologies Ltd.
Boston University
CareDx, Inc.
CD Diagnostics, Inc.
Chronix Biomedical, Inc.
Co-Diagnostics HBDC, Inc.
Crescendo Bioscience, Inc.
Digna Biotech, S.L.
Durin Technologies, Inc.
Enterome Bioscience SA
Ezose Sciences Inc.
Flamentera AG
Genalyte, Inc.
Genentech, Inc.
GeNeuro SA
Glycominds Ltd.
Grifols, S.A.
Hannover Medical School
Helmholtz Centre for Infection Research
HOB Biotech Group Co., Ltd.
Hospital for Special Surgery
Hycor Biomedical Inc.
Ignyta, Inc.
ImmusanT, Inc.
Innobiochips
INOVA Diagnostics, Inc.
Institut National de la Sante et de la Recherche Medicale
Is Diagnostics
LineaGen, Inc.
Lophius Biosciences GmbH
Louisville Bioscience, Inc.
Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
Medica Corporation
Metabolomic Technologies Inc.
Metanomics Health GmbH
MSDx, Inc.
Myriad Genetics, Inc.
Nanosphere, Inc.
Neuro Vigor, LLC
Northwestern University
NoToPharm s.r.l.
NOWDiagnostics
OmniBiome Therapeutics Inc.
One Way Liver Genomics, S.L.
OPKO Health, Inc.
Oxford Gene Technology Limited
Oxford Immunotec Limited
Pediatric Bioscience, LLC
Progentec Diagnostics, Inc.
Protagen AG
ProteinLogic Ltd
Quanterix Corporation
Regulus Therapeutics Inc.
Rice University
Roche Diagnostics International Ltd.
Shuwen Biotech Co. Ltd.
Singulex, Inc.
SomaLogic, Inc.
Southern Illinois University Carbondale
SQI Diagnostics Inc.
The Johns Hopkins University
The Walter and Eliza Hall Institute of Medical Research
TheraDiag SA
Thermo Fisher Scientific Inc.
Toscana Biomarkers Srl
Univalue Valorizacion, S.L.
University of California, San Francisco
University of Chicago
University of Colorado
University of Florida
University of Manchester
University of Oxford
University of Pecs
University Rovira i Virgili
US Biomarkers, Inc.
Washington University in St. Louis
XAir Diagnostics B.V.
XEPTAGEN SpA
Yale University

【レポートのキーワード】

自己免疫疾患用装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の自己免疫疾患用装置開発動向:医療機器パイプライン分析2015]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月06日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆